Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 877 (MIR877) is a short, non-coding RNA classified as a microRNA (miRNA). It functions primarily in post-transcriptional regulation of gene expression by binding to target messenger RNAs (mRNAs), affecting their stability and translational efficiency. MIR877 is involved in several biological processes and may play a dual role as either an oncogene or tumor suppressor, depending on cellular context. It has been implicated in the development of various diseases, notably several cancers (such as gastric and prostate cancer), as well as cervix and bladder diseases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 877 (MIR877).